The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 69 | — | 20.1x | Above average | |
Growth | 48 | 10.7% | 5.6% | Near average | |
Quality | 33 | -25.7% | 7.6% | Below average | |
Safety | 62 | 3.1x | 0.4x | Near average | |
Capital Return | 20 | — | 2.19% | Below average | |
Momentum | 42 | — | — | Near average | |
Sentiment | 27 | — | — | Below average |
AngioDynamics, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy AngioDynamics, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.

AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
The analyst outlook for ANGO has shifted toward uncertainty due to a decrease in the number of analysts covering the stock from two to only one in recent days, resulting in the loss of Consensus in favor of an individual estimate. Although the price target remains stable at 16.5 dollars, the significant gap between the high (22 dollars) and the low (12 dollars) reflects a sharp divergence in the estimation of the company's fair value.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.